Showing 171-180 of 3039 results for "".
Neuroretinitis From Cat Scratch Disease
https://modernod.com/topics/retina/neuroretinitis-from-cat-scratch-disease/39025/Your patient’s furry friend may be the source of sudden, painless vision loss.Is Orthokeratology a Dying Art?
https://modernod.com/topics/myopia/is-orthokeratology-a-dying-art/38296/Don’t let uncertainty or common myths lead you to overlook this valuable treatment option.Therapeutics in the 2025 Pipeline
https://modernod.com/topics/contact-lenses/therapeutics-in-the-2025-pipeline/38957/Get familiar with exciting new treatments coming to market this year.Innovations in Dry Eye Treatment
https://modernod.com/topics/ocular-surface/innovations-in-dry-eye-treatment-1/38119/What’s coming and what’s on the horizon.A Collaborative Approach to Geographic Atrophy Management
https://modernod.com/topics/retina/a-collaborative-approach-to-geographic-atrophy-management/48721/How optometrists and ophthalmologists can comanage these patients.Managing Demodex Blepharitis in Eyelash Extension Wearers
https://modernod.com/topics/ocular-surface/managing-idemodexi-blepharitis-in-eyelash-extension-wearers/38815/Two cases illustrate the importance of education on lid hygiene and the benefits of a new available treatment option.Monitoring Myopia Progression With the Myopia Master®
https://modernod.com/mod-issues/supplements-inserts/monitoring-myopia-progression-with-the-myopia-master/38640/Advocacy for the Future of Optometry’s Leadership
https://modernod.com/topics/health-policy/advocacy-for-the-future-of-optometrys-leadership/38814/The fourth and final part of this multipart series considers how to engage early career optometrists in advocacy efforts.Nutritional Supplements for Glaucoma
https://modernod.com/topics/glaucoma/nutritional-supplements-for-glaucoma/38342/Dietary recommendations for when your patients ask, “What else can I do?”Glucagon-Like Peptide 1 Receptor Agonists and the Eye
https://modernod.com/topics/nutritionpharmaceuticals/glucagon-like-peptide-1-receptor-agonists-and-the-eye/38808/These drugs offer a promising outlook as transformative therapies in glycemic control, weight management, and more, but what effect do they have on our patients’ ocular health?